Table 1: Baseline characteristics of
the study population.
|
Parameters |
Overall patients (n=1337) |
Standard 12 Lead ECG |
12 Lead Smartphone ECG |
Cardiologist’s Diagnosis |
|
Age in years (Mean±SD)
years |
54.42±14.58 |
|||
|
Female, n(%) |
455 (34.03) |
|||
|
Male, n(%) |
881 (65.89) |
|||
|
BMI(Mean)(Kg/m2) |
24.34 |
|||
|
Chest pain |
239 |
|||
|
Palpitations |
49 |
|||
|
Shortness of breath |
94 |
|||
|
Hypertension |
87 |
|||
|
COVID-19 |
65 |
|||
|
Pacemaker implantation |
37 |
|||
|
Smoker |
141 |
|||
|
Diabetic |
204 |
|||
|
Subjects on
Anti-Coagulant Drugs |
500 |
|||
|
Subjects on Diuretics
Drugs |
234 |
|||
|
Subjects on Antacid |
293 |
|||
|
Subjects on
Anti-Hypertensive Drugs |
453 |
|||
|
Subjects on
Anti-Anginal Drugs |
123 |
|||
|
Anti-Hyperlipidemic
Drugs |
350 |
|||
|
Hyperglycimic Drugs |
75 |
|||
|
Arrhythmic ECG |
NA |
141 |
130 |
108 |
|
Non Arrhythmic ECG |
NA |
1196 |
1207 |
1229 |